Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ ANLEIHEN-Woche #KW34 – 2025: Energiekontor, JDC, The Platform Group, Aream, LEEF, Dt. Rohstoff,... (Anleihen-Finder) +++ PLATFORM GROUP Aktie +4,84%

SMITH & NEPHEW Aktie

 >SMITH & NEPHEW Aktienkurs 
16.01 EUR    -0.2%    (Tradegate)
Ask: 16.295 EUR / 320 Stück
Bid: 16.045 EUR / 325 Stück
Tagesumsatz: 357 Stück
Realtime Kurs von 8 bis 22 Uhr!
SMITHNEPHEW Aktie über LYNX handeln
>SMITH & NEPHEW Performance
1 Woche: +0,3%
1 Monat: +21,6%
3 Monate: +26,8%
6 Monate: +27,4%
1 Jahr: +15,1%
laufendes Jahr: +34,3%
>SMITH & NEPHEW Aktie
Name:  SMITH & NEPHEW
Land:  Großbritannien
Sektor:  Gesundheit
ISIN/ Wkn:  GB0009223206 / 502816
Symbol/ Ticker:  NPW1 (Frankfurt)
Kürzel:  FRA:NPW1, ETR:NPW1, NPW1:GR
Index:  FTSE100
Webseite:  https://www.smith-nephew...
Profil:  Smith & Nephew plc is a distinguished global medic..
>Volltext..
Marktkapitalisierung:  13800.48 Mio. EUR
Unternehmenswert:  16161.36 Mio. EUR
Umsatz:  5412.83 Mio. EUR
EBITDA:  1415.42 Mio. EUR
Nettogewinn:  446.92 Mio. EUR
Gewinn je Aktie:  0.51 EUR
Schulden:  2969.48 Mio. EUR
Liquide Mittel:  581.17 Mio. EUR
Operativer Cashflow:  1038.93 Mio. EUR
Bargeldquote:  0.44
Umsatzwachstum:  1.21%
Gewinnwachstum:  54.88%
Dividende je Aktie:  0.35 EUR
Dividendenrendite:  2.11%
Dividendenschätzung:  2.06%
Div. Historie:  27.03.25 - 0.2149686€
03.10.24 - 0.13276799€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  SMITH & NEPHEW, SMITHNEPHEW, SMITH NEPHEW, SMITH&NEPHEW
Letzte Datenerhebung:  23.08.25
>SMITHNEPHEW Kennzahlen
Aktien/ Unternehmen:
Aktien: 871.97 Mio. St.
Frei handelbar: 97.53%
Rückkaufquote: -0.01%
Mitarbeiter: 18456
Umsatz/Mitarb.: 0.26 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: -1.5%
Bewertung:
KGV: 31.68
KGV lG: 18.72
KUV: 2.6
KBV: 2.95
PEG-Ratio: 0.56
EV/EBITDA: 11.42
Rentabilität:
Bruttomarge: 70.04%
Gewinnmarge: 8.26%
Operative Marge: 15.29%
Managementeffizenz:
Gesamtkaprendite: 4.7%
Eigenkaprendite: 9.3%
 >SMITHNEPHEW Anleihen 
Es sind 1 Anleihen zur SMITH & NEPHEW Aktie bekannt.
>SMITHNEPHEW Peer Group

Es sind 81 Aktien bekannt.
 
20.08.25 - 13:06
IN BRIEF: Smith & Nephew director David King buys $100,000 in shares (Alliance)
 
Smith & Nephew PLC - Watford, England-based medical devices maker - Non-Executive Director David King buys 2,800 American...
06.08.25 - 16:00
FTSE 100 Live: index gains erased, despite jumps for Smith & Nephew, BP and Diageo (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.25 - 10:00
FTSE 100 Live: stocks surge as Diageo, Smith & Nephew and BP results impress (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 17:48
FTSE 100 Live: stocks called higher as Diageo, Smith & Nephew and Fresnillio results impress (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 15:12
The Smith & Nephew share price is up 14% today. Here′s why the FTSE 100 stock could be just getting started (Fool)
 
FTSE 100 healthcare stock Smith & Nephew remains well below its pre-Covid highs. But it's now starting to motor higher and Edward Sheldon sees room to run. The post The Smith & Nephew share price is up 14% today. Here's why the FTSE 100 stock could be just getting started appeared first on The Motley Fool UK....
05.08.25 - 14:48
Smith+Nephew maintain guidance as it lifts profits and cash flow, launches $500 million buyback after strong first half (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 14:33
FTSE 100 today: Index extends gains; BP beats, Smith & Nephew rallies (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 14:24
This FTSE 100 share’s rocketed 15% today! Is it a top momentum stock to buy? (Fool)
 
Smith & Nephew's share price has soared again at the start of August! Can this FTSE 100 turnaround share keep up the pace? The post This FTSE 100 share's rocketed 15% today! Is it a top momentum stock to buy? appeared first on The Motley Fool UK....
05.08.25 - 14:00
FTSE 100 Live: stocks surge as Diageo, Smith & Nephew and BP results impress (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 11:12
Smith & Nephew Non-GAAP EPS of $0.43, revenue of $2.96B; reaffirms FY outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 11:06
Smith & Nephew shares jump 16% as sales growth picks up in 2nd quarter (Alliance)
 
Smith & Nephew PLC on Tuesday claimed its transformation was starting to deliver substantial value, as it said revenue growth...
05.08.25 - 09:48
Smith & Nephew Surges on $500 Million Buyback Plan, Profit Beat (Bloomberg)
 
Smith & Nephew Plc surged after reporting better-than-expected earnings and announcing a $500 million share buyback, rewarding shareholders after a years-long turnaround effort....
05.08.25 - 09:36
Smith & Nephew H1 Results Climb, Backs FY25 Outlook; Plans $500 Mln Buyback (AFX)
 
LONDON (dpa-AFX) - British medical equipment maker Smith & Nephew Plc (SN.L, SNN) reported Tuesday higher profit and revenues in its first half, and maintained fiscal 2025 outlook, expecting reven......
05.08.25 - 08:51
Smith & Nephew tops trading profit forecasts in H1 on cost cuts, U.S. recovery (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
07.07.25 - 16:03
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option (GlobeNewswire EN)
 
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle. ...
29.06.25 - 13:03
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair (GlobeNewswire EN)
 
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world's oldest and most prestigious tennis tournament serves as a perfect backdrop to showcase Smith+Nephew's purpose of 'Life Unlimited' - making a difference in patients' lives through the excellence of a diverse Sports Medicine product portfolio and the application of new technologies....
26.06.25 - 18:15
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System (Zacks)
 
Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair....
24.06.25 - 16:03
Smith+Nephew′s new TRIGEN™ MAX Tibia Nailing System brings ′next-level nailing′ to trauma surgeons repairing tibial fractures (GlobeNewswire EN)
 
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology...
23.06.25 - 15:42
Smith & Nephew hires Mckinsey alum Ajay Dhankar to executive board (Alliance)
 
Smith & Nephew PLC on Monday said it had hired Ajay Dhankar, ex-senior partner at Mckinsey & Co, to its executive board. The Watford, Hertfordshire-based......
23.06.25 - 14:03
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer (GlobeNewswire EN)
 
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. ...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Politiker verschweigt oft auch das, was er nicht weiß. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!